Cargando…
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis
This study is aimed at describing tofacitinib and baricitinib users by characterizing their prescription and healthcare histories, drug and healthcare utilization patterns, and direct costs from a healthcare system perspective. This retrospective cohort study was performed using Tuscan administrativ...
Autores principales: | Convertino, Irma, Lorenzoni, Valentina, Gini, Rosa, Turchetti, Giuseppe, Fini, Elisabetta, Giometto, Sabrina, Bartolini, Claudia, Paoletti, Olga, Ferraro, Sara, Cappello, Emiliano, Valdiserra, Giulia, Bonaso, Marco, Blandizzi, Corrado, Tuccori, Marco, Lucenteforte, Ersilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058541/ https://www.ncbi.nlm.nih.gov/pubmed/36986565 http://dx.doi.org/10.3390/ph16030465 |
Ejemplares similares
-
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy
por: Convertino, Irma, et al.
Publicado: (2023) -
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases
por: Convertino, Irma, et al.
Publicado: (2021) -
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study
por: Convertino, Irma, et al.
Publicado: (2021) -
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients
por: Convertino, Irma, et al.
Publicado: (2020) -
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance
por: Tuccori, Marco, et al.
Publicado: (2020)